| You are here: Home » Costs » Septic hip arthritis » other |
Score: n/a SD: (n/a)
Open Statement: Septic hip arthritis
Subgroup: other 
Posted by Thomas Maurer
| Title | Author | Journal | Year | Paper level (mean) |
Readers vote (mean) |
Number of Voters |
|||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Preferences for health outcomes associated with Group A Streptococcal disease and vaccination. | Lee, Grace M; Salomon, Joshua A; Gay, Charlene; Hammitt, James K; | Health and quality of life outcomes | 2010 | 0.00 |  |
0.00 | 0 |
|
| 2 | [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. | Jahoda, D; Nyc, O; Pokorný, D; Landor, I; Sosna, A; | Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca | 2006 | 0.00 | |
0.00 | 0 |
|
| 3 | [Standardized sonographic examination of the hip joint]. | Konermann, W; Gruber, G; Gaa, J; | Ultraschall in der Medizin (Stuttgart, Germany : 1980) | 2000 | 0.00 | |
0.00 | 0 |
|
| 4 | Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. | Carson, J L; Altman, D G; Duff, A; Noveck, H; Weinstein, M P; Sonnenberg, F A; Hudson, J I; Provenzano, G; | Transfusion | 1999 | 0.00 | |
0.00 | 0 |
|
| 5 | The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis. | Swart, Joost Frans; Barug, Daantje; Möhlmann, Michelle; Wulffraat, Nico M; | Expert opinion on biological therapy | 2010 | 0.00 | |
0.00 | 0 |
|